Suchergebnisse - (Person:"Apkon, Susan")

PubPharm (7)

1

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy

enthalten in: Neurology | 2017

von Victor, R. | Sweeney, H. | Finkel, R. | +77

2

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2017

von McDonald, C. | Campbell, C. | Torricelli, R. | +72

CommentIn: Lancet. 2017 Sep 23;390(10101):1467-1468. - PMID 28728957

3

Association Between Facility Type During Pediatric Inpatient Rehabilitation and Functional Outcomes

enthalten in: Archives of physical medicine and rehabilitation | 2016

von Fuentes, M. | Apkon, S. | Jimenez, N. | +1

4

Electrical impedance myography in Duchenne muscular dystrophy and healthy controls : A multicenter study of reliability and validity

enthalten in: Muscle & nerve | 2015

von Zaidman, C. | Wang, L. | Connolly, A. | +22

5

Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies

enthalten in: Muscle & nerve | 2014

von Pettygrove, S. | Lu, Z. | Andrews, J. | +9

6

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy : reliability, concurrent validity, and minimal clinically important differences from a multicenter study

enthalten in: Muscle & nerve | 2013

von McDonald, C. | Henricson, E. | Abresch, R. | +56

CommentIn: Muscle Nerve. 2013 Sep;48(3):315-7. - PMID 24038058

7

The 6-minute walk test and other endpoints in Duchenne muscular dystrophy : longitudinal natural history observations over 48 weeks from a multicenter study

enthalten in: Muscle & nerve | 2013

von McDonald, C. | Henricson, E. | Abresch, R. | +56

CommentIn: Muscle Nerve. 2013 Sep;48(3):315-7. - PMID 24038058

1
[1]